ePrints

Why is it hard to terminate failing projects in pharmaceutical R&D?

Lookup NU author(s): Dr Dennis LendremORCiD, Dr Clare LendremORCiD, Professor John IsaacsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

'Quick-kill' strategies in pharmaceutical research and development aim to reduce late-stage attrition by bringing project termination decisions forward, to an earlier point in the development process. How can the barriers to implementing such strategies be overcome?

Publication metadata

Author(s): Peck RW, Lendrem DW, Grant I, Lendrem BC, Isaacs JD

Publication type: Article

Publication status: Published

Journal: Nature Reviews Drug Discovery

Year: 2015

Volume: 14

Pages: 1-2

Online publication date: 21/08/2015

Acceptance date: 21/08/2015

ISSN (print): 1474-1776

ISSN (electronic): 1474-1784

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/nrd4725

DOI: 10.1038/nrd4725

Altmetrics

Share